SAS Output

21-OCT-2018 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1613-mCRC, Adv/Met, TP vs CETIRI 1 Y 0 Screening 130 85 85 65 33 10 2 11/27/2017 330 128
            85 85 65 33 10 2      
 
    2 Y 1 Trastuzumab + Pertuzumab 130 4 4 3 0 0 0 11/27/2017    
        2 Cetuximab + Irinotecan   6 6 6 2 1 0      
            10 10 9 2 1 0      
 
    3 Y 3 Crossover: Trastuz + Pertuz 130 2 2 2 2 0 0 11/27/2017    
            2 2 2 2 0 0      
 
Yes A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC 1 E Total Registrations   6 6 4 1 0 0 03/23/2018 96 39
            6 6 4 1 0 0      
 
  N1048-Rectal,LocalAdv,ChemoRT+/-FOLFOX 1 E Total Registrations   163 31 15 8 5 0 06/05/2013 362 157
            163 31 15 8 5 0      
 
No A021501-Adeno Panc,Borderline Resect,Chemo vs ChemoRT 0 E Total Registrations   18 7 1 0 0 0 05/01/2017 150 57
            18 7 1 0 0 0      
 
    1 E Total Registrations   15 6 1 0 0 0 05/01/2017    
            15 6 1 0 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   4 0 0 0 0 0 07/14/2016 188 75
            4 0 0 0 0 0      
 
  EA2161-PANC, Adv Rapalog Resistant PNETs, MLN0128 1 E Total Registrations   1 1 1 1 0 0 09/06/2018   1
            1 1 1 1 0 0      
 
  EA2165-Anal, Stg II-III, Nivolumab after CMT 1 E Total Registrations   1 1 1 1 1 0 10/09/2018    
            1 1 1 1 1 0      
 
  NRGGI002-Rectal, Ph II, Sensitization using TNT 1 E Total Registrations   8 6 2 2 2 2 02/21/2017 352 149
            8 6 2 2 2 2      
 
  NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy 1 E Total Registrations   3 3 2 2 0 0 04/18/2018 92 35
            3 3 2 2 0 0